110 related articles for article (PubMed ID: 6232913)
21. Bromocriptine and Huntington's chorea.
Frattola L; Albizzatir MG; Trabucchi M
Arch Neurol; 1978 Jan; 35(1):60. PubMed ID: 145841
[No Abstract] [Full Text] [Related]
22. Therapeutic experience with transdihydrolisuride in Huntington's disease.
Bassi S; Albizzati MG; Corsini GU; Frattola L; Piolti R; Suchy I; Trabucchi M
Neurology; 1986 Jul; 36(7):984-6. PubMed ID: 2940475
[TBL] [Abstract][Full Text] [Related]
23. Studies of hypothalamic function in Huntington's chorea.
Lavin PJ; Bone I; Sheridan P
J Neurol Neurosurg Psychiatry; 1981 May; 44(5):414-8. PubMed ID: 6455503
[TBL] [Abstract][Full Text] [Related]
24. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.
van Vugt JP; Siesling S; Vergeer M; van der Velde EA; Roos RA
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):35-9. PubMed ID: 9221965
[TBL] [Abstract][Full Text] [Related]
25. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
[TBL] [Abstract][Full Text] [Related]
26. Effects of terguride in patients with Huntington's disease.
Stocchi F; Carta A; Berardelli A; Antonini A; Argenta M; Formica A; Agnoli A
Clin Neuropharmacol; 1989 Oct; 12(5):435-9. PubMed ID: 2575450
[TBL] [Abstract][Full Text] [Related]
27. Klinefelter's syndrome: effects of oestrogen on growth hormone, prolactin and thyrotrophin release, and on thyrotrophin and prolactin responses to thyrotrophin-releasing hormone.
Barbarino A; De Marinis L
Acta Endocrinol (Copenh); 1979 Oct; 92(2):347-57. PubMed ID: 115199
[No Abstract] [Full Text] [Related]
28. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
[TBL] [Abstract][Full Text] [Related]
29. Bromocriptine in Huntington chorea.
Kartzinel R; Hunt RD; Calne DB
Arch Neurol; 1976 Jul; 33(7):517-8. PubMed ID: 132915
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology of Huntington's chorea. Personal experience.
Caraceni T; Giovannini P; Girotti F; Avanzini G
Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
[TBL] [Abstract][Full Text] [Related]
31. Altered growth hormone release in Huntington's chorea.
Keogh HJ; Johnson RH; Nanda RN; Sulaiman WR
J Neurol Neurosurg Psychiatry; 1976 Mar; 39(3):244-8. PubMed ID: 132511
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
Muechler EK; Huang KE; McDonald JV; Tang L
Am J Obstet Gynecol; 1987 Aug; 157(2):453-5. PubMed ID: 3113252
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of hyperprolactinemia and acromegaly with lisuride].
Berezin M; Elchalal U; Olchovsky D
Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946
[TBL] [Abstract][Full Text] [Related]
34. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
[No Abstract] [Full Text] [Related]
35. Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine.
Carlson HE; Linfoot JA; Braunstein GD; Kovacs K; Young RT
Am J Med; 1983 May; 74(5):915-23. PubMed ID: 6340497
[TBL] [Abstract][Full Text] [Related]
36. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Sadoul JL; Thyss A; Freychet P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.
Verde G; Chiodini PG; Liuzzi A; Cozzi R; Favales F; Botalla L; Spelta B; Dalla Bonzana D; Rainer E; Horowski R
J Endocrinol Invest; 1980; 3(4):405-14. PubMed ID: 6782153
[TBL] [Abstract][Full Text] [Related]
38. [Neuroendocrine study in 2 children with headache treated with lisuride].
D'Artoma G
Minerva Med; 1982 Mar; 73(12):673-6. PubMed ID: 6278368
[No Abstract] [Full Text] [Related]
39. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
[TBL] [Abstract][Full Text] [Related]
40. Age-associated changes in secretory patterns of growth hormone, prolactin and thyrotropin and the hormonal responses to thyrotropin-releasing hormone in rams.
Morrison MW; Davis SL; Spicer LJ
J Anim Sci; 1981 Jul; 53(1):160-70. PubMed ID: 6798007
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
